within Pharmacolibrary.Drugs.S_SensoryOrgans.S01A_Antiinfectives.S01AA11_Gentamicin;

model Gentamicin
  extends Pharmacolibrary.Drugs.ATC.S.S01AA11
  // parameters inherited from base class, duplicate, uncomment and change if necesarry
  /*
  
    weight         = 70,
    F              = 1,
    Cl             = 1.25e-06,
    adminDuration  = 600,
    adminMass      = 80 / 1000000,
    adminCount     = 1,
    Vd             = 0.018,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.013,
    k12             = 2.222222222222222e-06,
    k21             = 2.222222222222222e-06
      
  */
  ;

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Gentamicin</td></tr><tr><td>ATC code:</td><td>S01AA11</td></tr><td>route:</td><td>intravenous</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>80</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>18</td><td>L</td></tr>
    <tr><td>clearance:</td><td>4.5</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Gentamicin is an aminoglycoside antibiotic used to treat serious gram-negative bacterial infections and some gram-positive infections. It is commonly administered by intravenous or intramuscular routes in hospital settings. Gentamicin is approved for clinical use and remains a standard treatment option for severe infections.</p><h4>Pharmacokinetics</h4><p>Mean pharmacokinetic parameters reported in healthy adults after intravenous administration, typically studied in hospitalized patients with normal renal function.</p><h4>References</h4><ol><li><p>Medellín-Garibay, SE, et al., &amp; Barcia, E (2015). Population pharmacokinetics of gentamicin and dosing optimization for infants. <i>Antimicrobial agents and chemotherapy</i> 59(1) 482–489. DOI:<a href=\"https://doi.org/10.1128/AAC.03464-14\">10.1128/AAC.03464-14</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25385111/\">https://pubmed.ncbi.nlm.nih.gov/25385111</a></p></li><li><p>Boisson, M, et al., &amp; Grégoire, N (2018). Pharmacokinetics of intravenous and nebulized gentamicin in critically ill patients. <i>The Journal of antimicrobial chemotherapy</i> 73(10) 2830–2837. DOI:<a href=\"https://doi.org/10.1093/jac/dky239\">10.1093/jac/dky239</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29947799/\">https://pubmed.ncbi.nlm.nih.gov/29947799</a></p></li><li><p>Lares-Asseff, I, et al., &amp; Lugo Goytia, G (2016). Population Pharmacokinetics of Gentamicin in Mexican Children With Severe Malnutrition. <i>The Pediatric infectious disease journal</i> 35(8) 872–878. DOI:<a href=\"https://doi.org/10.1097/INF.0000000000001204\">10.1097/INF.0000000000001204</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27420805/\">https://pubmed.ncbi.nlm.nih.gov/27420805</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Gentamicin;
